Form 4: Sage Therapeutics Executive Anne Marie Cook Reports Stock Transactions

Anne Marie Cook, SVP, GC & Secretary of Sage Therapeutics, reports acquisition and disposal of company stock related to PSU vesting and tax withholding.

Summary

• Anne Marie Cook, a Senior Vice President, General Counsel, and Secretary at Sage Therapeutics, reported transactions involving the company's common stock.
• On August 5, 2024, Ms. Cook acquired 13,500 shares of common stock upon the vesting of Performance Stock Units (PSUs) granted on February 13, 2024.
• The PSUs vested due to the achievement of certain milestones.
• Also on August 5, 2024, Ms. Cook disposed of 4,503 shares to cover tax obligations at a price of $8.96 per share.
• Following these transactions, Ms. Cook beneficially owns 24,040 shares of Sage Therapeutics common stock.
• Ms. Cook also owns 1,112 shares purchased on June 28, 2024 under the Sage Therapeutics, Inc. 2014 Employee Stock Purchase Plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing primarily reflects routine stock transactions related to executive compensation.

Positives

• The vesting of Performance Stock Units indicates the achievement of certain company milestones.

Negatives

• The disposal of shares to cover tax obligations reduces the executive's holdings.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are often related to compensation packages and equity-based incentives.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.

Key Dates